Skip to main content
MedPathMedPath Home
Clinical Trials/DRKS00015730
DRKS00015730
Completed
Not Applicable

se of illicit drugs during pregnancy and its risks and outcomes for mother and child - focus cannabisPilot project CaSCH-T1 - CaSCH-T1

Klinikum der Universität MünchenForschungsgruppe Cannabinoide (Ltg. PD Dr. Eva Hoch)0 sites1,548 target enrollmentDecember 18, 2018
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsDSM-5: substance use disorderF10-F19Mental and behavioural disorders due to psychoactive substance use

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
DSM-5: substance use disorder
Sponsor
Klinikum der Universität MünchenForschungsgruppe Cannabinoide (Ltg. PD Dr. Eva Hoch)
Enrollment
1548
Status
Completed
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 18, 2018
End Date
March 13, 2019
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
Klinikum der Universität MünchenForschungsgruppe Cannabinoide (Ltg. PD Dr. Eva Hoch)

Eligibility Criteria

Inclusion Criteria

  • •It is planned to receive completed questionnaires from 200 pregnant women/mothers and 50 medical qualified personnel who treat pregnant women/mothers with substance use.

Exclusion Criteria

  • •Interested participants who do not fit in one of the below defined populations are not eligible for participation at the online survey:
  • •\- Pregnant woman or mother
  • •\- Physician, midwife or other medical qualified personnel who treats pregnant women/mothers with substance use

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Not Applicable
Prevalence of substance use and their effects in pregnancy
CTRI/2022/02/040367Maulana azad medical college and Lok Nayak hospital
Recruiting
Not Applicable
Evaluation of Drug's Risk in Pregnant WomenPregnancy
NCT02818842University Hospital, Toulouse30,000
Completed
Not Applicable
Safety of anthelmintic medication during pregnancy: An evaluation of pregnancy outcomes based on the Embryotox cohortQ89.9O03P95Congenital malformation, unspecifiedSpontaneous abortionFetal death of unspecified cause
DRKS00032898Pharmakovigilanz- und Beratungszentrum für Embryonaltoxikologie Charité – Universitätsmedizin Berlin323
Completed
Not Applicable
Computer-delivered Screening & Brief Intervention for Marijuana Use in PregnancyMarijuana UsePregnancy
NCT02191605Wayne State University60
Completed
Not Applicable
Pregnancy and Use of Psychoactive Substances: The Influence of Representations of Care on Care.Pregnancy
NCT03567070University Hospital, Caen9